2.70
+0.02(+0.75%)
Currency In USD
| Previous Close | 2.68 |
| Open | 2.67 |
| Day High | 2.81 |
| Day Low | 2.61 |
| 52-Week High | 9.37 |
| 52-Week Low | 2.5 |
| Volume | 242,704 |
| Average Volume | 379,398 |
| Market Cap | 108.7M |
| PE | -1.88 |
| EPS | -1.44 |
| Moving Average 50 Days | 3.08 |
| Moving Average 200 Days | 5.78 |
| Change | 0.02 |
If you invested $1000 in Pulmonx Corporation (LUNG) since IPO date, it would be worth $68.68 as of July 16, 2025 at a share price of $2.7. Whereas If you bought $1000 worth of Pulmonx Corporation (LUNG) shares 3 years ago, it would be worth $173.41 as of July 16, 2025 at a share price of $2.7.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 8:05 PM GMT
REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Goldman
Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
GlobeNewswire Inc.
May 01, 2025 8:05 PM GMT
REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America Se
Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025
GlobeNewswire Inc.
Apr 16, 2025 8:05 PM GMT
REDWOOD CITY, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter